Joseph Fleming has dedicated his career to excellence in the fields of pharmacy and healthcare services. He holds a B.S. in Pharmacy and an M.S. in Pharmacology from Northeastern University. In 2005, he founded the Health Science Entrepreneurs (HSE) at Northeastern. HSE is a volunteer organization of alumni and friends who have founded health science companies and who desire to give back to the university. Several times a year, alumni in the healthcare industry return to campus for discussion of healthcare issues and to mentor entrepreneurial students and alumni. He is chairman of HSE and currently involved in an active mentoring program for young health science companies. The program is funded through direct contributions from alumni and friends.
Mr. Fleming is the Chairman of Infusion Ventures, Inc., an infusion nursing company servicing several New England states. Mr. Fleming cofounded the company in 2010 to participate in the growing filed of vascular access. The company employs vascular access nurses who specialize in infusion therapy management in patients’ homes. Professional staff consists of CRNI, PICC and peripheral IV certified nurses who provide specialized treatment to pediatric, adolescent, adult and geriatric patients.
Mr. Fleming served as Executive in Residence at Beecken Petty O’Keefe private equity, focused entirely on healthcare investments, from 20007-2009. He sourced several specialty pharmacy and home infusion deals while at Beecken Petty.
In September of 2003, Mr. Fleming co-founded Specialty Pharma, Inc. (SPI) and led a management buy-out of Professional Home Care Services, Inc., partnered with Eureka Growth Capital. SPI is a comprehensive specialty infusion and pharmacy company that provides high quality service and intravenous drugs to patients in a variety of alternate site settings combined with low-cost, high-growth mail order distribution of self-injectable drugs. SPI grew to service over 2,500 patients per month in southern New England. As chairman, Mr. Fleming negotiated and executed several distribution and disease management agreements with biotech manufacturers. The company was successfully sold in 2006.
Mr. Fleming was also co-founder, president and chief executive officer of Community Rehab Centers, one of the largest networks of rehabilitation centers in the eastern US.